Neutrophils and the increased risk of cardiovascular events in severe COPD

K. Yazaki, N. Kamada, Y. Fujibe, M. Kashima, K. Asakura, M. Sato, T. Sato, K. Kikuchi (Yuri-Honjo, Akita, Japan)

Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care
Session: Distinguishing phenotypes and dealing with comorbidities in primary care
Session type: Thematic Poster Session
Number: 3702
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Yazaki, N. Kamada, Y. Fujibe, M. Kashima, K. Asakura, M. Sato, T. Sato, K. Kikuchi (Yuri-Honjo, Akita, Japan). Neutrophils and the increased risk of cardiovascular events in severe COPD. Eur Respir J 2012; 40: Suppl. 56, 3702

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011

Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016


COPD and respiratory viral infections as risk factors for the development of cardiovascular events
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020


The impact of airway infection on cardiovascular risk during COPD exacerbations
Source: Annual Congress 2012 - Acute exacerbation in COPD
Year: 2012

Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes
Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Year: 2011

In people at high risk of cardiovascular disease, co-existing COPD is not independently associated with macrovascular or microvascular disease
Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD
Year: 2018



Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia
Source: Eur Respir J 2014; 43: 36-42
Year: 2004



COPD is associated with an increased risk of peripheral artery disease and mortality
Source: ERJ Open Res, 4 (4) 00086-2018; 10.1183/23120541.00086-2018
Year: 2018



The risk of cardiovascular disease associated with asthma may be mediated by short-acting β2-agonists
Source: Annual Congress 2008 - Epidemiology of asthma and allergy
Year: 2008


Risk factors contributing to mortality in patients with COPD developing acute respiratory failure
Source: Eur Respir J 2007; 30: Suppl. 51, 557s
Year: 2007

Acute exacerbation in COPD and relationship between cardiovascular risk and functional profile
Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings
Year: 2018




The impact of aging on COPD, cardiovascular comorbidities and systemic inflammation
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019

Chronic asthma and the risk of cardiovascular disease
Source: Eur Respir Monogr 2020; 88: 82-95
Year: 2020


The risk of hyperkalemia in COPD and asthma patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019


Exacerbations and mortality of COPD patients with cardiovascular disease in the UK
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010

Risk factors for mortality in patients with COPD exacerbation
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009

Exacerbations in severe persistent asthma - impact of risk factors control
Source: Eur Respir J 2005; 26: Suppl. 49, 683s
Year: 2005

Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD
Source: Eur Respir J 2016; 47:1365-1373
Year: 2016



COPD the unseen factor causing increased morbidity and mortality among IHD patients
Source: Annual Congress 2009 - COPD case-finding and management in primary care
Year: 2009